Cosmos HoldingsCOSM
About: Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
Employees: 123
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
20% more funds holding
Funds holding: 15 [Q3] → 18 (+3) [Q4]
6.56% less ownership
Funds ownership: 13.52% [Q3] → 6.97% (-6.56%) [Q4]
13% less call options, than puts
Call options by funds: $13K | Put options by funds: $15K
48% less capital invested
Capital invested by funds: $2.1M [Q3] → $1.08M (-$1.02M) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for COSM.
Financial journalist opinion
Based on 11 articles about COSM published over the past 30 days









